Scotland commits to postal chlamydia screening - England squanders £300m
This article was originally published in Clinica
The NHS in Scotland today pledged its commitment to using a postal testing kit to boost screening for chlamydia, as part of a £15m ($28m) three-year drive to improve access to sexual health services. The announcement was made in the run-up to Sexual Health Week (August 7-13).
You may also be interested in...
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
Through its partnership with majority stakeholder Nanjing King-Friend Biochemical Pharmaceutical, Meitheal Pharmaceuticals has received FDA approval for enoxaparin, a generic rival to Lovenox.